FDA classifies 122,021-case Gatorade recall; UAE pharmacies should check imports

PepsiCo recalled 122,021 cases of 28-ounce Gatorade bottles in the U.S. after undeclared Yellow No. 5 and Yellow No. 6 were found in selected labels, a food-safety alert that UAE pharmacies and clinics should treat as a stock-verification exercise rather than a confirmed local withdrawal.

The item appeared in Patch's 6 October 2026 Tuscaloosa daily roundup under the headline "Disturbance In Gulf | Pillars Of West Alabama Named | Gatorade Recall". The underlying recall was initiated by PepsiCo on 25 September 2026 and classified by the U.S. Food and Drug Administration (FDA) as Class II on 2 October 2026, according to FDA-linked recall coverage.

What was recalled

The recall covers selected Gatorade Lemon Lime, Gatorade Lemon Lime Zero, Gatorade Orange and Gatorade Orange Zero in 28-ounce bottles. The stated issue is undeclared synthetic colour additives on the ingredient panel, not a bacterial outbreak and not a declared contamination event. The U.S. distribution list covers 37 states, including Alabama, Florida, Georgia, Texas, California, New York and New Jersey, according to ConsumerLab's recall summary.

UAE operators should check lot codes before taking any action. Public recall summaries list date codes including APR 18 27, APR 20 27, APR 23 27, APR 25 27, APR 27 27, APR 28 27, MAY 07 27, MAY 17 27, MAY 22 27, JUN 01 27, JUN 07 27 and JUN 08 27. Clinics should ask patients to retain the bottle or photograph the cap, label and batch code if they report symptoms after use.

• COOs: ask procurement teams to check whether any 28-ounce U.S.-sourced Gatorade stock entered clinic vending, sports medicine or pharmacy channels.
• CFOs: document discarded stock by SKU, batch and supplier invoice before seeking distributor credit.
• Medical directors: flag dye sensitivity when triaging urticaria, wheeze or gastrointestinal symptoms after sports drink consumption.
• CIOs: add the recalled SKUs and date codes to stock-control and incident-reporting fields for seven days, then review hits.

Why UAE clinics and insurers should care

In Dubai, food products and consumer recalls sit with Dubai Municipality food-safety controls, while healthcare facilities and pharmacies are licensed by the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain, healthcare licensing sits with the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, healthcare facilities and pharmacies are licensed by the Ministry of Health and Prevention (MOHAP). The split matters because a clinic may see the reaction, while the product control action may sit outside the clinic's healthcare licence file.

The UAE retail price signal is small but operationally relevant. Noon Minutes listed 495ml Gatorade products in Dubai, Abu Dhabi and Sharjah at about AED 5.40 to AED 5.95 this week, according to Noon Minutes listings. The financial exposure for one clinic fridge is modest. The compliance exposure is in traceability: undocumented disposal, incomplete supplier notices or staff giving patients unverified safety claims.

For insurers, the issue is claims hygiene. Daman, Thiqa and Sukoon adjudicate UAE medical claims under policy terms and network rules. Providers should record the suspected product, symptom onset time, treatment, allergy history and whether the patient had the bottle available. That record helps distinguish a minor outpatient visit from an emergency presentation and gives claims teams a clean audit trail if several patients report the same exposure.

What operators should do now

Dubai clinics should first check whether any product came through direct U.S. import, staff purchase, gym partnerships or vending suppliers. If a matching bottle is found, quarantine it, photograph the code, notify the distributor and follow Dubai Municipality guidance. Abu Dhabi and Al Ain providers should apply the same stock check and keep DOH-facing incident records if a patient presentation occurs. Northern Emirates providers should keep MOHAP facility records complete and use the relevant municipal or federal food-safety channel for product questions.

Patients with known sensitivity to Yellow No. 5 or Yellow No. 6 should avoid affected U.S. lot codes and seek medical advice if symptoms occur after consumption. Patients without symptoms do not need an emergency visit solely because they bought Gatorade. The practical step is to check the bottle size, flavour and date code, then contact the retailer or distributor if the code matches the public recall list.

For pharmacy sourcing and patient referrals, use the UAE Open Healthcare Directory to find licensed pharmacy providers across Dubai, Abu Dhabi, Al Ain and the northern emirates.